Chemoprevention in bladder cancer: What’s new?

Authors

  • Jean-Baptiste Lattouf Department of Surgery, Urologic Oncology Section and Minimally Invasive Section, University of Montréal Health Centre (CHUM), Montréal, QC

DOI:

https://doi.org/10.5489/cuaj.1193

Abstract

Bladder cancer is the sixth most common tumour in Canada and
ranks eighth in terms of cancer mortality. Up to now, management
of this condition relied mostly on surgical and intravesical
treatments once the disease is established. Chemoprevention is an
attractive option to prevent the disease in high-risk populations
and may well reduce the costs related to its treatment. This review
examines the available data on chemoprevention strategies in bladder
cancer, with special emphasis on randomized controlled trials
when available.

Downloads

Download data is not yet available.

Author Biography

Jean-Baptiste Lattouf, Department of Surgery, Urologic Oncology Section and Minimally Invasive Section, University of Montréal Health Centre (CHUM), Montréal, QC

Downloads

How to Cite

Lattouf, J.-B. (2013). Chemoprevention in bladder cancer: What’s new?. Canadian Urological Association Journal, 3(6-S4), S184-S187. https://doi.org/10.5489/cuaj.1193